{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "infants aged 6\u201324 months undergoing craniofacial reconstruction surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "three escalating loading dose\u2013continuous i.v. infusion (CIVI) regimens: 25 mg kg \u22121 , 10 mg kg \u22121 h \u22121 ; 50 mg kg \u22121 , 20 mg kg \u22121 h \u22121 ; 100 mg kg \u22121 , 40 mg kg \u22121 h \u22121"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study is to determine the pharmacokinetics (PKs) of EACA in infants aged 6\u201324 months undergoing craniofacial reconstruction surgery."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 5,
    "max_score": 25
  },
  "model": "gpt-4o"
}